Immunovant, Inc. (NASDAQ: IMVT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT IMMUNOVANT, INC.

Immunovant, Inc. (NASDAQ: IMVT)
Listen to this Section


$31.22
-1.4500 ( -4.44% ) 366.1K

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

Market Data


Open $31.22
Previous Close $32.67
Volume 366.1K
Market Cap $6.71B
Day Range $30.94 - $34.10
52 Week Range $14.32 - $36.29
Shares Outstanding 205.31M
Change % -4.44%
Net Change ▼ -1.4500
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Nov 10, 2025
10-q Quarterly Reports 58 Nov 10, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 10, 2025
4 Insider transactions 1 Oct 10, 2025
8-k 8K-related 37 Sep 03, 2025
8-k 8K-related 12 Aug 28, 2025
8-k 8K-related 13 Aug 11, 2025
10-q Quarterly Reports 61 Aug 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy